IrishExaminer.com
Decision due on Skyclarys funding as Biogen reportedly makes lower price offer
Families affected by Friedreich’s ataxia remain hopeful as the HSE considers the treatment’s cost and benefits for patients
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.